RT-PCR analysis of blood RNA obtained from NS-3 treated people with T2DM for 24-weeks resulted down-regulation of gene expression in diabetes biomarkers (IRS-1, SOD-2, GCKR, IGFPB-2) compared to pre-dose values [34]. The gene discussed is SOD2; the disease is type 2 diabetes mellitus.